New York, New York - July 11, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a snapshot of recent news from biopharma stocks reporting developments for the treatment of lung cancer. Sunshine Biopharma Inc. (OTCBB: SBFM) reported news on its lead compound, Adva-27a and OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced an update on its lead product, custirsen.
READ MORE AT:
http://www.investorideas.com/CO/SBFM/news/2012/07111.asp






Add new comment